Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug
In a victory for Gilead, Brazilian antitrust authorities dismissed a complaint about the company''s prices for a hepatitis C drug.
Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug
In a victory for Gilead, Brazilian antitrust authorities dismissed a complaint about the company''s prices for a hepatitis C drug.